Publication:
Recommendations for the treatment of invasive fungal infections in hematological malignancies: A critical review of evidence and Turkish Expert Opinion (TEO-1)

Simple item page
dc.contributor.authorAkan, Hamdi
dc.contributor.authorÖngören, Şeniz
dc.contributor.authorSaltoğlu, Neşe
dc.contributor.authorÇağatay, Arif Atahan
dc.contributor.authorArat, Mutlu Ersöz
dc.contributor.authorKalayoğlu, Sevgi B.
dc.contributor.authorDemir, Ahmet Muzaffer
dc.contributor.buuauthorAkalın, Halis
dc.contributor.buuauthorAli, Rıdvan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentHematoloji Ana Bilim Dalı
dc.contributor.departmentEnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı
dc.contributor.researcheridAAU-8952-2020
dc.contributor.scopusid57207553671
dc.contributor.scopusid7201813027
dc.date.accessioned2024-02-08T06:29:52Z
dc.date.available2024-02-08T06:29:52Z
dc.date.issued2014-05-12
dc.description.abstractThe introduction of novel antifungal agents for the treatment of invasive fungal disease in hematological malignancies and also changing treatment strategies have had a great impact in managing affected patients. The medical literature includes some important clinical studies that are being used as evidence for guidelines. The problem with these studies and the guidelines is that they are not very easy to interpret, they include controversial issues, and they are not easy to apply to every patient or country. This paper was designed to critically show the main problems associated with these approaches and provide important information that will help Turkish doctors to adopt them in daily clinical practice.
dc.identifier.citationAkalın, H. vd. (2014). "Recommendations for the treatment of invasive fungal infections in hematological malignancies: A critical review of evidence and Turkish Expert Opinion (TEO-1)". Turkish Journal of Hematology, 31(2), 111-120.
dc.identifier.endpage120
dc.identifier.issn1300-7777
dc.identifier.issn1308-5263
dc.identifier.issue2
dc.identifier.pubmed25035667
dc.identifier.scopus2-s2.0-84905912115
dc.identifier.startpage111
dc.identifier.urihttps://doi.org/10.4274/tjh.2014.0103
dc.identifier.urihttps://jag.journalagent.com/tjh/pdfs/TJH_31_2_111_120.pdf
dc.identifier.urihttps://hdl.handle.net/11452/39593
dc.identifier.volume31
dc.identifier.wos000338094600001
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherGalenos Publ House
dc.relation.collaborationYurt içi
dc.relation.collaborationSanayi
dc.relation.journalTurkish Journal of Hematology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAntifungal treatment
dc.subjectInvasive fungal infection
dc.subjectEvidence
dc.subjectHematological malignancies
dc.subjectLiposomal amphotericin-b
dc.subjectEfficacy
dc.subjectPreemptive antifungal therapy
dc.subjectVoriconazole
dc.subjectNeutropenic patients
dc.subjectAmbisome
dc.subjectEmpirical-treatment
dc.subjectFebrile
dc.subjectPersistent fever
dc.subjectHigh-risk
dc.subjectHematology
dc.subject.emtreeAllogeneic stem cell transplantation
dc.subject.emtreeAntifungal activity
dc.subject.emtreeAntimicrobial therapy
dc.subject.emtreeAntiviral therapy
dc.subject.emtreeAspergillosis
dc.subject.emtreeAutologous stem cell transplantation
dc.subject.emtreeCandidemia
dc.subject.emtreeCandidiasis
dc.subject.emtreeDrug efficacy
dc.subject.emtreeEsophagus candidiasis
dc.subject.emtreeFeasibility study
dc.subject.emtreeFebrile neutropenia
dc.subject.emtreeHematologic malignancy
dc.subject.emtreeHigh risk patient
dc.subject.emtreeHodgkin disease
dc.subject.emtreeHuman
dc.subject.emtreeMulticenter study (topic)
dc.subject.emtreeMultiple myeloma
dc.subject.emtreeMycosis
dc.subject.emtreeMyelodysplastic syndrome
dc.subject.emtreeNephrotoxicity
dc.subject.emtreeNeutropenia
dc.subject.emtreeNonhodgkin lymphoma
dc.subject.emtreeNonhuman
dc.subject.emtreePhase 1 clinical trial (topic)
dc.subject.emtreePhase 2 clinical trial (topic)
dc.subject.emtreePhysician
dc.subject.emtreeRandomized controlled trial (topic)
dc.subject.emtreeReview
dc.subject.emtreeSystemic mycosis
dc.subject.emtreeAmphotericin b.
dc.subject.emtreeAmphotericin b deoxycholate
dc.subject.emtreeAmphotericin b lipid complex
dc.subject.emtreeAntifungal agent
dc.subject.emtreeCaspofungin
dc.subject.emtreeEchinocandin
dc.subject.emtreeGalactomannan
dc.subject.emtreeTriazole
dc.subject.emtreeVoriconazole
dc.subject.scopusAntifungal Agents; Posaconazole; Micafungin
dc.subject.wosHematology
dc.titleRecommendations for the treatment of invasive fungal infections in hematological malignancies: A critical review of evidence and Turkish Expert Opinion (TEO-1)
dc.typeArticle
dc.wos.quartileQ4 (Hematology)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Hematoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atScopus

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
TJH_31_2_111_120.pdf
Size:
141.74 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

İndeksli Yayınlar / Indexed Publications